At 10.5% CAGR, the Europe Poultry Diagnostic Market is Projected to be Worth US$ 121.36 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe poultry diagnostic market was valued at US$ 54.50 million in 2022 and is expected to reach US$ 121.36 million by 2030, registering a CAGR of 10.5% from 2022 to 2030. Rising zoonotic disease cases and technological advancements attributed to the Europe poultry diagnostic market expansion.        

Zoonotic diseases are caused by harmful viruses, bacteria, parasites, and fungi. These germs cause different illnesses, ranging from mild to severe, in humans and animals, which may even lead to fatalities. According to the World Health Organization (WHO) 2023 report, ~60% of the emerging infectious diseases reported globally are zoonoses. Additionally, in the last two decades, the emergence of various zoonotic diseases has been reported in 18 out of 22 countries, resulting in explosive outbreaks and high fatalities. Advancements in biotechnology and molecular epidemiology have made it easier to develop vaccines and therapeutics, and diagnostics processes (tools, equipment, consumables, etc.) to identify and track the transmission of zoonoses. iVetNet is an information platform run and maintained by the International Atomic Energy Agency (IAEA) in cooperation with the Food and Agriculture Organization of the United Nations (FAO) to compile, disseminate, and harmonize techniques for the detection and characterization of transboundary animal and zoonotic pathogens. Launched in 2022, iVetNet can bring together over 1,000 laboratories and offering users access to the information, validation, and verified procedures for the detection and characterization of animal and skin disease, Ebola, Zika, and COVID-19.

On the contrary, insufficient welfare measures for poultry hampers the Europe poultry diagnostic market.  

Based on test type, the Europe poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held 47.0% share of Europe poultry diagnostic market in 2022, amassing US$ 25.63 million. It is projected to garner US$ 59.27 million by 2030 to expand at 11.0% CAGR during 2022–2030. 

In terms of disease, the Europe poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held 29.9% share of Europe poultry diagnostic market in 2022, amassing US$ 16.31 million. It is projected to garner US$ 37.08 million by 2030 to expand at 10.8% CAGR during 2022–2030.

By country, the Europe poultry diagnostic market has been categorized into Germany, Spain, France, UK, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe poultry diagnostic market in 2022. It was assessed at US$ 16.27 million in 2022 and is likely to hit US$ 37.99 million by 2030, exhibiting a CAGR of 11.2% during 2022–2030.      

Key players operating the Europe poultry diagnostic market are Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and BioInGenTech Biotechnologies, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com